macroH2A2 antagonizes epigenetic programs of stemness in glioblastoma.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
27 05 2023
Historique:
received: 19 11 2021
accepted: 22 05 2023
medline: 29 5 2023
pubmed: 28 5 2023
entrez: 27 5 2023
Statut: epublish

Résumé

Self-renewal is a crucial property of glioblastoma cells that is enabled by the choreographed functions of chromatin regulators and transcription factors. Identifying targetable epigenetic mechanisms of self-renewal could therefore represent an important step toward developing effective treatments for this universally lethal cancer. Here we uncover an epigenetic axis of self-renewal mediated by the histone variant macroH2A2. With omics and functional assays deploying patient-derived in vitro and in vivo models, we show that macroH2A2 shapes chromatin accessibility at enhancer elements to antagonize transcriptional programs of self-renewal. macroH2A2 also sensitizes cells to small molecule-mediated cell death via activation of a viral mimicry response. Consistent with these results, our analyses of clinical cohorts indicate that high transcriptional levels of this histone variant are associated with better prognosis of high-grade glioma patients. Our results reveal a targetable epigenetic mechanism of self-renewal controlled by macroH2A2 and suggest additional treatment approaches for glioblastoma patients.

Identifiants

pubmed: 37244935
doi: 10.1038/s41467-023-38919-2
pii: 10.1038/s41467-023-38919-2
pmc: PMC10224928
doi:

Substances chimiques

Histones 0
Chromatin 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3062

Subventions

Organisme : CIHR
ID : PJT-156278
Pays : Canada

Informations de copyright

© 2023. The Author(s).

Références

Genes Dev. 2010 Jan 1;24(1):21-32
pubmed: 20008927
Science. 2014 Jun 20;344(6190):1396-401
pubmed: 24925914
Cell. 2014 Apr 24;157(3):580-94
pubmed: 24726434
Cell Stem Cell. 2020 Jan 2;26(1):48-63.e6
pubmed: 31901251
Nature. 2006 Dec 7;444(7120):756-60
pubmed: 17051156
Nat Commun. 2020 Jul 8;11(1):3406
pubmed: 32641768
Bioinformatics. 2016 Jan 15;32(2):289-91
pubmed: 26424858
Cancer Lett. 2013 Aug 19;336(2):247-52
pubmed: 23531411
J Immunol Methods. 2009 Aug 15;347(1-2):70-8
pubmed: 19567251
Mol Cell. 2018 Jan 4;69(1):36-47.e7
pubmed: 29249653
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Nature. 2012 Aug 23;488(7412):522-6
pubmed: 22854781
Nat Methods. 2021 Nov;18(11):1333-1341
pubmed: 34725479
Nat Med. 2017 Nov;23(11):1352-1361
pubmed: 29035367
Nat Methods. 2015 Apr;12(4):326-8
pubmed: 25730490
Cell Rep. 2019 Apr 16;27(3):971-986.e9
pubmed: 30995489
Nat Neurosci. 2008 Dec;11(12):1392-401
pubmed: 18849983
Genome Res. 2013 Aug;23(8):1210-23
pubmed: 23636943
N Engl J Med. 2019 Jun 6;380(23):2237-2245
pubmed: 31167052
Nat Commun. 2019 Nov 19;10(1):5228
pubmed: 31745090
Nat Commun. 2022 Jul 19;13(1):4178
pubmed: 35853870
Nat Commun. 2022 Aug 15;13(1):4767
pubmed: 35970913
Nat Methods. 2017 Jul;14(7):687-690
pubmed: 28581496
Natl Sci Rev. 2020 Aug;7(8):1306-1318
pubmed: 34692159
Nature. 2014 Mar 27;507(7493):455-461
pubmed: 24670763
Nucleic Acids Res. 2016 Jul 8;44(W1):W160-5
pubmed: 27079975
Nat Commun. 2021 Apr 12;12(1):2184
pubmed: 33846316
Bioinformatics. 2009 Jun 1;25(11):1463-5
pubmed: 19346324
Nat Rev Genet. 2016 Apr;17(4):207-23
pubmed: 26948815
Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
Oncogene. 2009 Sep 24;28(38):3423-8
pubmed: 19648962
Nat Cancer. 2021 Feb;2(2):141-156
pubmed: 33681822
Neurobiol Dis. 2019 Dec;132:104514
pubmed: 31229690
Cell. 2018 Aug 9;174(4):1015-1030.e16
pubmed: 30096299
Cancer Cell. 2010 Jan 19;17(1):98-110
pubmed: 20129251
Mol Cell Biol. 2007 Mar;27(6):2343-58
pubmed: 17242207
Cell Stem Cell. 2010 May 7;6(5):421-32
pubmed: 20452317
Oncogene. 2004 Sep 20;23(43):7274-82
pubmed: 15378087
Elife. 2021 Jan 11;10:
pubmed: 33427645
Genome Biol. 2014;15(12):550
pubmed: 25516281
Nat Biotechnol. 2016 May;34(5):525-7
pubmed: 27043002
Cancer Res. 2003 Sep 15;63(18):5821-8
pubmed: 14522905
Nat Cancer. 2021 Feb;2(2):157-173
pubmed: 35122077
Cancer Cell. 2015 Dec 14;28(6):715-729
pubmed: 26626085
Genes Dev. 2002 Jan 15;16(2):165-70
pubmed: 11799060
Cell Rep. 2013 May 30;3(5):1567-79
pubmed: 23707066
Nature. 1998 Jun 11;393(6685):599-601
pubmed: 9634239
J Clin Oncol. 2008 Jun 20;26(18):3015-24
pubmed: 18565887
Cancer Discov. 2019 Dec;9(12):1708-1719
pubmed: 31554641
Cancer Res. 2013 Jan 1;73(1):417-27
pubmed: 23108137
Nature. 2010 Dec 23;468(7327):1105-9
pubmed: 21179167
Nature. 2019 Dec;576(7785):112-120
pubmed: 31748746
Nat Genet. 2021 Oct;53(10):1469-1479
pubmed: 34594037
Nature. 2017 Sep 14;549(7671):227-232
pubmed: 28854171
Nature. 2017 Jul 20;547(7663):355-359
pubmed: 28678782
Cell. 2022 Aug 4;185(16):2899-2917.e31
pubmed: 35914528
Development. 2004 May;131(10):2349-58
pubmed: 15102707
Cancer Res. 2009 Dec 1;69(23):9065-72
pubmed: 19920198
Nat Biotechnol. 2014 Sep;32(9):941-6
pubmed: 24952903
Dev Cell. 2005 Jan;8(1):19-30
pubmed: 15621527
Nature. 2004 Nov 18;432(7015):396-401
pubmed: 15549107
Cell Rep. 2017 May 30;19(9):1758-1766
pubmed: 28564596
Stem Cell Reports. 2015 Jul 14;5(1):1-9
pubmed: 26095605
Cell Stem Cell. 2009 Jun 5;4(6):568-80
pubmed: 19497285
Cancer Res. 2009 Dec 15;69(24):9211-8
pubmed: 19934320
Neuron. 2016 Jan 6;89(1):37-53
pubmed: 26687838
Cell. 2013 Oct 10;155(2):462-77
pubmed: 24120142
Hum Mol Genet. 2006 Mar 1;15(5):717-24
pubmed: 16421169
Nat Struct Mol Biol. 2018 Oct;25(10):958-970
pubmed: 30291361
Cell. 2016 Jan 28;164(3):550-63
pubmed: 26824661
Nat Methods. 2013 Dec;10(12):1213-8
pubmed: 24097267
Neuro Oncol. 2022 Sep 1;24(9):1494-1508
pubmed: 35416251
Cell Death Differ. 2012 Mar;19(3):428-39
pubmed: 21836617
Genome Biol. 2008;9(9):R137
pubmed: 18798982
Nat Struct Mol Biol. 2009 Sep;16(9):923-9
pubmed: 19680243
Nat Commun. 2013;4:1565
pubmed: 23463008
Mol Cell. 2010 May 28;38(4):576-89
pubmed: 20513432
EMBO Rep. 2021 Jul 5;22(7):e52150
pubmed: 34046991
Cell. 2019 Aug 8;178(4):835-849.e21
pubmed: 31327527
Nature. 2012 Feb 15;483(7390):479-83
pubmed: 22343889
Cancer Cell. 2012 Mar 20;21(3):283-96
pubmed: 22439924
Clin Cancer Res. 2009 Jul 15;15(14):4622-9
pubmed: 19584161
Nucleic Acids Res. 2009 Jan;37(1):1-13
pubmed: 19033363
Blood. 2012 Nov 29;120(23):4461-9
pubmed: 22936661
Bioinformatics. 2009 Aug 1;25(15):1952-8
pubmed: 19505939
Mol Cell Biol. 2011 Oct;31(20):4244-55
pubmed: 21844227
Cell. 2015 Aug 27;162(5):961-73
pubmed: 26317465
Proc Natl Acad Sci U S A. 2011 Jul 5;108(27):E265-74
pubmed: 21690374
Cancer Res. 2006 Apr 15;66(8):3987-91
pubmed: 16618716
Cell Stem Cell. 2017 Apr 6;20(4):450-461.e4
pubmed: 28089910
Dev Cell. 2022 Jan 10;57(1):32-46.e8
pubmed: 35016005
Commun Biol. 2022 May 19;5(1):482
pubmed: 35590030
J Biol Chem. 2001 Jun 15;276(24):21776-84
pubmed: 11262398
Nat Rev Genet. 2014 Apr;15(4):259-71
pubmed: 24614311
J Neurosci. 2009 Jul 15;29(28):8884-96
pubmed: 19605626
Methods Mol Biol. 2020;2117:135-157
pubmed: 31960376
Biochem Biophys Res Commun. 2011 Mar 25;406(4):643-8
pubmed: 21371437
Mol Cancer. 2006 Dec 02;5:67
pubmed: 17140455
Nat Chem Biol. 2012 Jan 29;8(3):277-84
pubmed: 22286128
Nat Methods. 2017 Oct;14(10):959-962
pubmed: 28846090
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Cancer Cell. 2019 May 13;35(5):782-797.e8
pubmed: 31085178
Cancer Res. 2004 Oct 1;64(19):7011-21
pubmed: 15466194
Development. 2008 Feb;135(4):637-46
pubmed: 18184726
Nat Rev Mol Cell Biol. 2017 May;18(5):299-314
pubmed: 28144029
J Cell Sci. 2012 Dec 15;125(Pt 24):6094-104
pubmed: 23077180
Nucleic Acids Res. 2019 Jul 2;47(W1):W171-W174
pubmed: 31106371
Clin Cancer Res. 2007 Apr 1;13(7):2038-45
pubmed: 17404084
Genome Res. 2018 Feb 15;:
pubmed: 29449408
Bioinformatics. 2010 Mar 15;26(6):841-2
pubmed: 20110278
Mol Cell Biol. 2012 Apr;32(8):1442-52
pubmed: 22331466
PLoS Genet. 2014 Aug 07;10(8):e1004515
pubmed: 25102063
Science. 2016 Sep 30;353(6307):
pubmed: 27708074
J Biol Chem. 2013 May 31;288(22):16110-6
pubmed: 23595991
EMBO Rep. 2018 Oct;19(10):
pubmed: 30177554
N Engl J Med. 2005 Mar 10;352(10):987-96
pubmed: 15758009
Neuro Oncol. 2017 Jun 1;19(6):796-807
pubmed: 28115578
Cell. 2015 Aug 27;162(5):974-86
pubmed: 26317466
Mol Cell. 2015 Sep 3;59(5):719-31
pubmed: 26300260
Nat Methods. 2019 Oct;16(10):1007-1015
pubmed: 31501550

Auteurs

Ana Nikolic (A)

Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Francesca Maule (F)

Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Anna Bobyn (A)

Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Department of Biological Sciences, Faculty of Science, University of Calgary, Calgary, AB, Canada.

Katrina Ellestad (K)

Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Seungil Paik (S)

Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Sajid A Marhon (SA)

Princess Margaret Cancer Centre, Toronto, ON, Canada.

Parinaz Mehdipour (P)

Princess Margaret Cancer Centre, Toronto, ON, Canada.
Ludwig Institute for Cancer Research, University of Oxford, Oxford, UK.

Xueqing Lun (X)

Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Huey-Miin Chen (HM)

Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Claire Mallard (C)

Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Alexander J Hay (AJ)

Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Michael J Johnston (MJ)

Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Christopher J Gafuik (CJ)

Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Franz J Zemp (FJ)

Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Yaoqing Shen (Y)

Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada.
Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.

Nicoletta Ninkovic (N)

Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Katalin Osz (K)

Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Elodie Labit (E)

Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Department of Compararive Biology and Experimental Medicine, Faculty of Veterinary Medicine, and Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

N Daniel Berger (ND)

Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Duncan K Brownsey (DK)

Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Department of Chemistry, Faculty of Science, University of Calgary, Calgary, AB, Canada.

John J Kelly (JJ)

Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Jeff Biernaskie (J)

Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Department of Compararive Biology and Experimental Medicine, Faculty of Veterinary Medicine, and Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Peter B Dirks (PB)

Program in Developmental and Stem Cell Biology, Hospital for Sick Children, Toronto, ON, Canada.
Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.

Darren J Derksen (DJ)

Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Department of Chemistry, Faculty of Science, University of Calgary, Calgary, AB, Canada.

Steven J M Jones (SJM)

Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada.
Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.

Donna L Senger (DL)

Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Jennifer A Chan (JA)

Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Douglas J Mahoney (DJ)

Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Department of Microbiology, Immunology and Infectious Diseases, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Daniel D De Carvalho (DD)

Princess Margaret Cancer Centre, Toronto, ON, Canada.
Department of Medical Biophysics, Faculty of Science, University of Toronto, Toronto, ON, Canada.

Marco Gallo (M)

Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada. marco.gallo@ucalgary.ca.
Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada. marco.gallo@ucalgary.ca.
Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada. marco.gallo@ucalgary.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH